[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339362-105":3,"doc-detail-339362-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","controlled-production-of-lipopolysaccharides-increases-immune-activation-in-salmonella-treatments-of-cancer","Controlled production of lipopolysaccharides increases immune activation in Salmonella treatments of cancer","","Immunotherapies for cancer depend on activation of immune cells within tumours, yet patient response rates remain limited. Lipopolysaccharides (LPS) can convert cold tumour microenvironments into hot ones by stimulating innate immunity, but systemic delivery risks cytokine storm. This study develops immune-controlling Salmonella (ICS) that produce LPS only in tumours after colonization and then clear systemically. Tuning msbB expression creates a controllable inflammatory program, boosts dendritic cell crosspresentation in vitro, and enhances tumour-selective immune activation. In mice, tumour-local LPS expression increases infiltration of immune cells, activates monocytes and neutrophils, elevates IL-6, stimulates CD8 T cells, reduces tumour growth, and improves survival. Strong off-state control prevents TNFα and adverse events, supporting localized bacterial anti-cancer therapy as an option for immune-resistant cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/controlled-production-of-lipopolysaccharides-increases-immune-activation-in-salmonella-treatments-of-cancer/339362/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/controlled-production-of-lipopolysaccharides-increases-immune-activation-in-salmonella-treatments-of-cancer/339362.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why can lipopolysaccharides improve cancer immunotherapy?","Question",{"text":63,"@type":64},"LPS can activate innate immune cells and convert tumour microenvironments from cold to hot, which increases therapeutic efficacy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What problem arises from systemic delivery of lipopolysaccharides?",{"text":68,"@type":64},"Systemic LPS delivery can induce excessive inflammatory signaling, including cytokine storm and related adverse events.",{"name":70,"@type":61,"acceptedAnswer":71},"How does immune-controlling Salmonella (ICS) address these risks?",{"text":72,"@type":64},"ICS are engineered to produce LPS only in tumours after colonization, while clearing systemically to maintain a controlled inflammatory response.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339362,1790161732,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267",8,"DOI: 10.1111/1751-7915 .14461  \nR E S E A R C H A R T I C L E  \nControlled production of lipopolysaccharides increases immune activation in Salmonella treatments of cancer  \nLars M. Howell1  | Simin Manole2  | Alec R. Reitter1  | Neil S. Forbes1,2,3   \n1Department of Chemical Engineering, University of Massachusetts Amherst, Amherst, Massachusetts, USA 2Molecular and Cellular Biology Program, University of Massachusetts Amherst, Amherst, Massachusetts, USA 3 Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, Massachusetts, USA  \nCorrespondence  \nNeil S. Forbes, Department of Chemical Engineering, University of Massachusetts Amherst, 159 Goessmann Laboratory, 686 North Pleasant St. , Amherst, Massachusetts 01003, USA.  \nEmail: [forbes@umass.edu](forbes@umass.edu)  \nFunding information  \nU. S. Department of Defense, Grant/ Award Number: HT94252310067 and W81XWH1910602; Center for Strategic Scientific Initiatives, National Cancer Institute, Grant/Award Number:  \nR01CA188382  \nAbstract  \nImmunotherapies have revolutionized cancer treatment. These treatments rely on immune cell activation in tumours, which limits the number of patients that respond. Inflammatory molecules, like lipopolysaccharides (LPS), can activate innate immune cells, which convert tumour microenvironments from cold to hot, and increase therapeutic efficacy. However, systemic delivery of lipopolysaccharides (LPS) can induce cytokine storm. In this work, we developed immune-controlling Salmonella (ICS) that only produce LPS in tumours after colonization and systemic clearance. We tuned the expression of msbB, which controls production of immunogenic LPS, by optimizing its ribosomal binding sites and protein degradation tags. This genetic system induced a controllable inflammatory response and increased dendritic cell crosspresentation in vitro. The strong off state did not induce TNFα production and prevented adverse events when injected into mice. The accumulation of ICSin tumours after intravenous injection focused immune responses specifically to tumours. Tumour-specific expression of msbB increased infiltration of immune cells, activated monocytes and neutrophils, increased tumour levels of IL-6, and activated CD8 T cells in draining lymph nodes. These immune responses reduced tumour growth and increased mouse survival. By increasing the efficacy of bacterial anti-cancer therapy, localized production of LPS could provide increased options to patients with immune-resistant cancers.  \nINTRODUCTION  \nImmunotherapies have revolutionized cancer treatment in recent years. However, not all patients respond to these therapies (Geethakumari et al. , 2021; Scheetz et al. , 2019 ; Taefehshokr et al. , 2022; Tokumaru et al. , 2020) . Effective immunotherapies rely on a“hot” tumour microenvironment with highly activated innate immune cells (Chouaib et al. , 1997; Dominieckiet al. , 2005) . There is a need for patient-independent, tumour-targeting immunotherapies. Delivery of innate immune cell-activating immunostimulatory molecules increases therapeutic efficacy and does not rely on knowledge of the patient-specific tumour antigens (Lee et al. , 2014; Pérez-Toledo et al. , 2017) . Because  \nsystemic injection of immunostimulatory molecules can lead to a cytokine storm, it is necessary to focus delivery specifically to the tumour microenvironment (Galanoset al. , 1972; Schletter et al. , 1995) . Controlled delivery of immunostimulatory molecules would increase localized inflammation, and by converting cold tumours to  \nhot tumours, would increase therapeutic efficacy.  \nSalmonella enterica serovar Typhimurium (designated here as “Salmonella”) localize to the tumour microenvironment at levels of 1000:1 and can be engineered to specifically produce their therapeutic cargo once localized to the tumour, overcoming a limitation of systemic delivery (Arrach et al. , 2008; Clairmont et al. , 2000 ; Forbes et al. , 2018) . Salmonella are facultative","cbCaicoFz2EFowUV","https://ap.wps.com/l/cbCaicoFz2EFowUV","pdf",3478313,16,"English","# Abstract\n# Introduction\n## Tumor microenvironment and immunotherapy responsiveness\n## Need for tumor-targeting and controlled innate immune activation\n## Salmonella localization and immune engagement via TLR-4 and LPS","[{\"question\":\"Why can lipopolysaccharides improve cancer immunotherapy?\",\"answer\":\"LPS can activate innate immune cells and convert tumour microenvironments from cold to hot, which increases therapeutic efficacy.\"},{\"question\":\"What problem arises from systemic delivery of lipopolysaccharides?\",\"answer\":\"Systemic LPS delivery can induce excessive inflammatory signaling, including cytokine storm and related adverse events.\"},{\"question\":\"How does immune-controlling Salmonella (ICS) address these risks?\",\"answer\":\"ICS are engineered to produce LPS only in tumours after colonization, while clearing systemically to maintain a controlled inflammatory response.\"}]","Controlled production of lipopolysaccharides increases immune activation in Salmonella treatments of cancer | PDF",1790029820,40,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/383804bbed87d534ee4130b5eb5056b4.webp",983,1291,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d91847c7693da33de8068a25352add44.webp",982,1290,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03a28f9f2707ed2f58799c3a373a5178.webp",981,1289,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3136a625752492a50dffc568057a91a.webp",980,1287,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,143,146,151,154,158],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":98,"slug":142},"Healthcare","healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":144,"slug":145},30,"research-report",{"id":147,"doc_module":4,"doc_module_name":25,"category_name":148,"show_sort_weight":149,"slug":150},9,"Religion & Spirituality",20,"religion-spirituality",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":152,"show_sort_weight":149,"slug":153},"World Cup","world-cup",{"id":155,"doc_module":4,"doc_module_name":25,"category_name":156,"show_sort_weight":155,"slug":157},10,"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":25,"category_name":160,"show_sort_weight":131,"slug":161},19,"General","general"]